A comprehensive view of Respiratory/Lung Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA to convene advisors to review experimental RSV vaccine candidate from Pfizer on February 28; group to meet in March to reviews RSV vaccine candidate from GSK
Published: February 03, 2023 by BioPharma Dive
Australia Patent: F. Hoffmann-La Roche Files Application for 'Compositions and methods for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-2), influenza A, and influenza B'
Published: February 03, 2023 by Australian Government
FDA approves AstraZeneca and Amgen’s Tezspire tezepelumab in a pre-filled, single-use pen for patients aged 12 and older with severe asthma; Tezspire is the only biologic approved for severe asthma with no phenotype for use at home or doctor’s office
Published: February 02, 2023 by AstraZeneca AB
Arcturus Therapeutics announces clinical trial application for ARCT-032 to treat cystic fibrosis received approval to proceed into first-in-human studies in New Zealand; ARCT-032 is an inhaled investigational mRNA medicine
Published: January 31, 2023 by Business Wire
Moderna granted FDA breakthrough therapy designation for its mRNA-1345 investigational RSV vaccine candidate in adults aged 60 years and older; in US, about 60,000-120,000 older adults are hospitalized with RSV every year
Published: January 30, 2023 by Moderna Inc.

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count